Semaglutide Synthetic Peptide C074PS Syd Labs | Ushelf
Semaglutide Synthetic Peptide C074PS Syd Labs | Ushelf

Semaglutide Synthetic Peptide | C074PS

Anti-HEL VHH-hIgG4 S228P Fc Isotype Control Antibody (Clone D3-L11) PA007165.h4 Syd Labs | Ushelf Anti-HEL VHH-hIgG4 S228P Fc Isotype Control Antibody (Clone: D3-L11) | PA007165.h4
Liraglutide Synthetic Peptide C073PS Syd Labs | Ushelf Liraglutide Synthetic Peptide | C073PS
Semaglutide Synthetic Peptide C074PS Syd Labs | Ushelf

Semaglutide Synthetic Peptide | C074PS

$400.00 – $3,200.00

In stock
Catalog No.: C074PS | In Vivo Grade

$400.00 – $3,200.00

Semaglutide Synthetic Peptide. Semaglutide Synthetic Peptide stable cell line is available for licensing to manufacture the semaglutide biosimilar. The research grade semaglutide biosimilar is for research use only (RUO).

Clear
View cart
Catalog No. C074PS
Product Name Semaglutide Synthetic Peptide
Supplier Name Syd Labs, Inc.
Brand Name Syd Labs
Source/Host The semaglutide peptide was synthesized.
Applications ELISA, functional assays such as bioanalytical PK and ADA assays, and those assays for studying biological pathways affected by semaglutide.
Endotoxin < 1 EU per 1 mg of the peptide by the LAL method.
Purity >95% by HPLC.
Shipping The research grade semaglutide synthetic peptide is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month from date of receipt, 2 to 8°C as supplied.
Note Semaglutide biosimilar stable cell line is available for licensing to manufacture the semaglutide biosimilar. The research grade semaglutide biosimilar is for research use only (RUO).
Order Offline Phone: 1-617-401-8149 Fax: 1-617-606-5022 Email: message@sydlabs.com Orleave a message with a formal purchase order (PO) Or credit card.

Description

C074PS: Semaglutide Synthetic Peptide

Background

What is research grade semaglutide biosimilar? Research grade semaglutide biosimilar has the same amino acid sequence as semaglutide, a recombinant peptide which presents 94% sequence homology to the human glucagon-like peptide-1 (GLP-1), differing primarily by two amino-acid substitutions at positions 8 and 34, where alanine and lysine are replaced by 2-aminoisobutyric acid and arginine, respectively. Liraglutide is made by attaching a C-18 fatty acid (stearic diacid) with a glutamic acid spacer on the remaining lysine residue at position 26 of the peptide precursor. Semaglutide is resistant to the dipeptidylpeptidase-4 enzyme whic degrades the natural hormone. As a GLP-1 receptor agonist, Semaglutide mimics the action of the human incretin glucagon-like peptide-1 (GLP-1), thereby increasing insulin secretion and increasing blood sugar disposal and improving glycemic control. Semaglutide is an anti-diabetic medication used to treat type 2 diabetes, obesity, and chronic weight management.

Syd Labs also provides the following GLP-1 receptor agonist biosimilar peptide:
Liraglutide biosimilar

Semaglutide Synthetic Peptide from: Semaglutide Synthetic Peptide: C074PS Syd Labs

You may also like…